These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 29797212)

  • 1. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
    Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.
    Umpierrez GE; Cuervo R; Karabell A; Latif K; Freire AX; Kitabchi AE
    Diabetes Care; 2004 Aug; 27(8):1873-8. PubMed ID: 15277410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Subcutaneous Rapid-Acting Insulin Aspart in the Treatment of Mild and Moderate Diabetic Ketoacidosis in Children: A Prospective Study.
    Talebi H; Razavi Z; Khazaei S
    Cureus; 2024 Jul; 16(7):e64241. PubMed ID: 39130949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children.
    Cohen M; Leibovitz N; Shilo S; Zuckerman-Levin N; Shavit I; Shehadeh N
    Pediatr Diabetes; 2017 Jun; 18(4):290-296. PubMed ID: 27005007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravenous insulin aspart for treatment of naturally occurring diabetic ketoacidosis in dogs.
    Walsh ES; Drobatz KJ; Hess RS
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):101-7. PubMed ID: 26379102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Cost-effectiveness of Subcutaneous Insulin Aspart in the Management of Mild Diabetic Ketoacidosis Among Children.
    Bali IA; Al-Jelaify MR; AlRuthia Y; Mulla JZ; Amlih DF; Bin Omair AI; Al Khalifah RA
    JAMA Netw Open; 2022 Sep; 5(9):e2230043. PubMed ID: 36066894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis.
    Gauntt J; Vaidyanathan P; Basu S
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):11-17. PubMed ID: 30530908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.
    Della Manna T; Steinmetz L; Campos PR; Farhat SC; Schvartsman C; Kuperman H; Setian N; Damiani D
    Diabetes Care; 2005 Aug; 28(8):1856-61. PubMed ID: 16043723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
    Vincent M; Nobécourt E
    Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis.
    Kwok R; Sztal-Mazer S; Hopkins RE; Poole SG; Grannell L; Coutsouvelis J; Topliss DJ
    Intern Med J; 2017 Nov; 47(11):1317-1320. PubMed ID: 29105262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children.
    Shankar V; Haque A; Churchwell KB; Russell W
    Intensive Care Med; 2007 Jul; 33(7):1173-1178. PubMed ID: 17508198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis.
    Gallagher BR; Mahony OM; Rozanski EA; Buob S; Freeman LM
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):234-9. PubMed ID: 25546713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile and outcomes of paediatric patients with diabetic ketoacidosis at a tertiary care hospital in Pakistan.
    Syed M; Khawaja FB; Saleem T; Khalid U; Rashid A; Humayun KN
    J Pak Med Assoc; 2011 Nov; 61(11):1082-7. PubMed ID: 22125983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of diabetic ketoacidosis management at a tertiary hospital in Johannesburg, South Africa.
    Thomas S; Mohamed NA; Bhana S
    S Afr Med J; 2019 May; 109(6):407-411. PubMed ID: 31266558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.
    Ersöz HO; Ukinc K; Köse M; Erem C; Gunduz A; Hacihasanoglu AB; Karti SS
    Int J Clin Pract; 2006 Apr; 60(4):429-33. PubMed ID: 16620355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher-Than-Conventional Subcutaneous Regular Insulin Doses Following Diabetic Ketoacidosis in Children and Adolescents.
    Bağ Ö; Tunç S; Nalbantoğlu Ö; Ecevit Ç; Öztürk A; Özkan B; Demir K
    J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):132-137. PubMed ID: 28044993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Management of Diabetic Ketoacidosis with Subcutaneous Rapid-acting Insulin Reduce the Need for Intensive Care Unit Admission?
    Cohn BG; Keim SM; Watkins JW; Camargo CA
    J Emerg Med; 2015 Oct; 49(4):530-8. PubMed ID: 26238182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.